10-15
2026
影响因子区间
—
平台估算
12%
2025
中国作者发文占比
1630 CHF;1820 USD;1600 EUR
收费
期刊简介:Blood Cancer Journal seeks to publish articles of the highest quality related to hematologic malignancies and related disorders. The Journal will consider for publication original research, reviews, guidelines and letters that are considered to be of high impact in the field.Topics of particular interest include, but are not limited to, the following:Preclinical studies of new compounds, especially those that provide mechanistic insightsClinical trials and observationsReviews related to new drugs and current management of hematologic malignanciesNovel observations related to new mutations, molecular pathways, and tumor genomics.
【译文】血液癌症杂志致力于发表与血液恶性肿瘤及其相关疾病最高质量的文章。该杂志将考虑发表原创研究、综述、指南和信函,这些内容被认为在领域内具有重大影响。特别感兴趣的主题包括但不限于以下内容:新化合物的临床前研究,特别是那些提供机制见解的研究;临床试验和观察;与新型药物和血液恶性肿瘤当前管理相关的综述;与新型突变、分子途径和肿瘤基因组学相关的新观察。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 中科院分区 | 1区 | 暂无 |
| 影响因子区间 | 10-15 | 暂无 |